These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 36322146)
1. Understanding the Symptom Burden and Impact of Myasthenia Gravis from the Patient's Perspective: A Qualitative Study. Jackson K; Parthan A; Lauher-Charest M; Broderick L; Law N; Barnett C Neurol Ther; 2023 Feb; 12(1):107-128. PubMed ID: 36322146 [TBL] [Abstract][Full Text] [Related]
2. Experience of Daily Life with Generalized Myasthenia Gravis: A Qualitative Investigation and Assessment of Instrument Content Validity. Hartford CA; Sherman SA; Karantzoulis S; Guillemin I; Phinney MG; Kelly KL; Negron KE; Raja SM; Rofail D Neurol Ther; 2023 Dec; 12(6):2079-2099. PubMed ID: 37747661 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study. Habib AA; Sacconi S; Antonini G; Cortés-Vicente E; Grosskreutz J; Mahuwala ZK; Mantegazza R; Pascuzzi RM; Utsugisawa K; Vissing J; Vu T; Wiendl H; Boehnlein M; Greve B; Woltering F; Bril V Ther Adv Neurol Disord; 2024; 17():17562864241273036. PubMed ID: 39297052 [TBL] [Abstract][Full Text] [Related]
4. Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO. Regnault A; Morel T; de la Loge C; Mazerolle F; Kaminski HJ; Habib AA Neurol Ther; 2023 Oct; 12(5):1573-1590. PubMed ID: 37166675 [TBL] [Abstract][Full Text] [Related]
5. Economic burden of generalized myasthenia gravis (MG) in the United States and the impact of common comorbidities and acute MG-events. Zhdanava M; Pesa J; Boonmak P; Cai Q; Pilon D; Choudhry Z; Souayah N Curr Med Res Opin; 2024 Jul; 40(7):1145-1153. PubMed ID: 38745448 [TBL] [Abstract][Full Text] [Related]
6. Quality of life in refractory generalized myasthenia gravis: A rapid review of the literature. Garzón-Orjuela N; van der Werf L; Prieto-Pinto LC; Lasalvia P; Castañeda-Cardona C; Rosselli D Intractable Rare Dis Res; 2019 Nov; 8(4):231-238. PubMed ID: 31890449 [TBL] [Abstract][Full Text] [Related]
7. Systematic review of the patient burden of generalised myasthenia gravis in Europe, the Middle East, and Africa. McCallion J; Borsi A; Noel W; Lee J; Karmous W; Sattler S; Boggia GM; Hardy EJ; Mitchell CR; Mitchell SA; Gilhus NE BMC Neurol; 2024 Feb; 24(1):61. PubMed ID: 38336636 [TBL] [Abstract][Full Text] [Related]
8. "Lower abdominal pains, as if I was being squeezed…in a clamp": A Qualitative Analysis of Symptoms, Patient-Perceived Side Effects and Impacts of Ovarian Cancer. Martin ML; Halling K; Eek D; Reaney M Patient; 2020 Apr; 13(2):189-200. PubMed ID: 31691205 [TBL] [Abstract][Full Text] [Related]
9. Impact of social determinants of health on individuals living with generalized myasthenia gravis and implications for patient support programs. Hughes T; Anderson AEL; Habib AA; Perez K; Bergin C; Suchotliff S; Zvosec C; McDaniel D; Sato M; Whangbo A; Phillips G Front Public Health; 2023; 11():1147489. PubMed ID: 37275500 [TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
11. Qualitative interviews to improve patient-reported outcome measures in late-onset Pompe disease: the patient perspective. Hamed A; An Haack K; Gwaltney C; Baranowski E; Stewart A; Krupnick R; Tyler M; Sparks S; Paty J Orphanet J Rare Dis; 2021 Oct; 16(1):428. PubMed ID: 34641935 [TBL] [Abstract][Full Text] [Related]
12. The economic burden of individuals living with generalized myasthenia gravis and facing social determinants of health challenges. Hughes T; Howard JF; Silvestri NJ; Anderson AEL; Sato M; Suchotliff S; Guptill JT; Phillips G Front Public Health; 2023; 11():1247931. PubMed ID: 37766748 [TBL] [Abstract][Full Text] [Related]
13. Understanding the impact of non-alcoholic steatohepatitis with metabolic comorbidities on adults: a real-world qualitative study. Shinde S; Taylor N; Chinthammit C; Wilson R; Burgess SM; Poon JL Curr Med Res Opin; 2024 Apr; 40(4):665-676. PubMed ID: 38363353 [TBL] [Abstract][Full Text] [Related]